Every 8-K that Petco Health and Wellness Company, Inc. (WOOF) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow WOOF and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full WOOF filings page.
Petco Health & Wellness Company, Inc. (WOOF) reported second quarter 2026 net sales of $1.49 billion, up 0.05% year over year, with comparable sales up 0.6%. Results include a $6.8 million net benefit from IEEPA tariff refunds tied to 2025–2026 tariffs.
Gross profit rose to $591.1 million, expanding gross margin to 39.7%, while operating income increased to $47.8 million. Net income grew to $38.7 million from $14.0 million and Adjusted EBITDA reached $122.2 million. Year-to-date free cash flow was $60.8 million, and quarter-end cash was $293.5 million.
Total debt was $1.48 billion with net debt of $1.19 billion; subsequent to quarter-end, the company prepaid $75 million of debt, part of $170 million of prepayments over nine months, supporting its 2x leverage ratio target. Petco reaffirmed its full-year 2026 outlook for net sales (flat to up 1.5%) and Adjusted EBITDA of $415–$430 million, and guided Q3 2026 net sales growth of 0.4–1.0% and Adjusted EBITDA of $100–$103 million.
Petco Health and Wellness Company, Inc. reported board changes effective August 1, 2026. Director Cameron Breitner resigned from the board and its committees, with the company stating his resignation was not due to any disagreement regarding operations, policies or practices.
The board appointed Jeffrey Naylor as an independent Class I director and Chair of the Audit Committee, effective immediately after the resignation. The board determined he qualifies as independent under Nasdaq rules and Rule 10A-3 and noted he is a designee of controlling stockholder Scooby Aggregator, LP under a Stockholder’s Agreement. Naylor will enter into Petco’s standard director indemnification agreement and receive compensation under its director compensation program. A press release dated August 3, 2026 announced his appointment.
Petco Health and Wellness Company, Inc. reports that on July 13, 2026, Chief Human Resources Officer Holly May notified Chief Executive Officer Joel Anderson of her decision to resign for personal reasons.
May is expected to remain in her current role to assist with the transition of her responsibilities through a date to be mutually agreed upon with the company. Petco has initiated a comprehensive search for her successor, a senior leadership role overseeing the company’s people and talent strategies.
Petco Health and Wellness Company, Inc. held its 2026 annual meeting of stockholders, where investors approved several governance items and an increase to the company’s equity compensation pool.
Stockholders approved a Second Amendment to the 2021 Equity Incentive Plan, adding 15,500,000 shares of Class A common stock reserved for employee and director equity awards. They also re-elected four Class III directors—Joel Anderson, Gary Briggs, Nishad Chande, and Mary Sullivan—to three-year terms.
In addition, stockholders approved, on a non-binding advisory basis, the compensation of the company’s named executive officers and ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending January 30, 2027.
Petco Health and Wellness Company reported first-quarter 2026 results showing modest growth and improved profitability metrics but a continued net loss. Net sales were $1.50 billion, up 0.2% year over year, with comparable sales up 0.7%.
Gross profit rose to $574.4 million and gross margin expanded to 38.4%. Operating income increased to $24.6 million and Adjusted EBITDA reached $97.3 million, though net loss widened slightly to $15.1 million. Free cash flow was an outflow of $69.1 million.
The company ended the quarter with 1,378 stores, cash of $166.8 million and total debt of $1.48 billion. Management reaffirmed full-year 2026 guidance, including flat to 1.5% net sales growth and Adjusted EBITDA of $415–$430 million, and guided Q2 2026 net sales to grow about 0.3% with Adjusted EBITDA of $110–$112 million.
Petco Health and Wellness Company reported fourth quarter and full year 2025 results that show a return to modest profitability and stronger cash generation despite lower sales. Full year net sales were $6.0 billion, down 2.5%, with comparable sales down 1.6%, but net income improved to $9.1 million from a loss of $101.8 million. Adjusted EBITDA rose 21.3% to $408.2 million, lifting the Adjusted EBITDA margin to 6.8% from 5.5%. Cash from operations increased 76.8% to $314.1 million and free cash flow reached $186.9 million. The company reduced its net debt/Adjusted EBITDA leverage ratio to 3.0x from 4.2x and ended the year with $256.7 million in cash. For 2026, Petco guides to flat to 1.5% net sales growth and Adjusted EBITDA of $415 million to $430 million, with 15–20 net store closures and Q1 sales expected down 1% to flat.
Petco Health and Wellness Company, Inc. appointed Glenn Murphy, previously Executive Chairman, as non-employee Chairman of the Board effective February 1, 2026. This change shifts his role from an executive position to an independent board leadership capacity.
In connection with the transition, Mr. Murphy will receive a lump sum payment of $9,615.38 as statutory pay under his May 13, 2024 offer letter and remains eligible for an annual bonus for fiscal 2025, payable when executive officer bonuses are paid. Petco also issued a press release on February 2, 2026 to publicly announce his appointment as Chairman.
Petco Health and Wellness Company, Inc. entered into a Second Amendment to its First Lien Credit Agreement on February 2, 2026. New refinancing term loans of $900 million, together with cash and $600 million of 8.250% senior secured notes due 2031, will repay the existing term loan facility.
The refinancing term loans bear interest at Term Benchmark plus 4.25%, or at the Company’s option Base Rate plus 3.25%, include a 1.00% soft call premium on certain repricings within six months, amortize 1.00% per year, and mature five years after the amendment date. The 8.250% notes carry restrictive covenants and can be redeemed early at specified prices, including a make-whole premium before February 1, 2028.
Petco Health and Wellness Company, Inc. is issuing $600 million of 8.250% senior secured notes due 2031. The company expects the sale of these notes to close on February 2, 2026, subject to customary closing conditions.
The notes will be guaranteed by subsidiaries that already guarantee Petco’s credit facilities. They will be secured with first-lien priority on fixed assets and second-lien priority on current assets, and will sit at different levels of priority versus other existing secured and unsecured debt depending on collateral and lien ranking.
Petco plans to use the net proceeds from the notes, together with borrowings under a new term loan facility and cash on hand, to fully repay its existing term loan facility, cover related fees and expenses, and for general corporate purposes. The company announced these financing plans through a press release furnished as an exhibit.
Petco Health and Wellness Company, Inc. plans to raise $650 million through an offering of senior secured notes due 2031. These notes will be guaranteed by subsidiaries that already guarantee the company’s credit facilities and will be secured by first-lien interests on fixed assets and second-lien interests on current assets.
The company intends to use the net proceeds from the notes, together with borrowings under a new term loan facility and cash on hand, to repay its existing term loan facility in full, cover related fees and expenses, and support general corporate purposes.
Petco Health and Wellness Company, Inc. filed a current report to disclose that it has launched a debt refinancing transaction and issued a press release about this step. At the same time, the company reaffirmed its previously provided fourth quarter and full fiscal year 2025 outlook for Net Sales and Adjusted EBITDA, indicating that its expectations for sales and profitability measures remain unchanged.
The press release containing further details is included as Exhibit 99.1 to the report and is furnished under a section that is not treated as filed for liability purposes under the Securities Exchange Act.
Petco Health and Wellness Company, Inc. (WOOF) filed a Form 8-K announcing that it issued a press release with its financial results for the quarter ended November 1, 2025. The press release is provided as Exhibit 99.1.
The company scheduled a webcast call at 4:30 p.m. Eastern Time on November 25, 2025 to discuss these results, with an accompanying earnings presentation and replay available on its investor relations website. The information furnished under Items 2.02 and 7.01, including Exhibit 99.1, is designated as furnished rather than filed under the Exchange Act.
Petco Health and Wellness Company, Inc. filed a current report to furnish a press release with its financial results for the quarter ended August 2, 2025. The press release, dated August 28, 2025, is included as Exhibit 99.1.
The company scheduled a webcast at 4:30 p.m. Eastern Time on August 28, 2025 to discuss these quarterly results, with an accompanying earnings presentation and a replay to be made available on its investor relations website. The information under Items 2.02 and 7.01, including Exhibit 99.1, is being furnished rather than filed under the Exchange Act and is not automatically incorporated into other Securities Act or Exchange Act filings.
Petco Health and Wellness Company, Inc. filed a current report to share that it will participate in the 32nd Annual Goldman Sachs Global Retailing Conference. The presentation is scheduled for September 4, 2025 at approximately 1:50 p.m. Eastern Time.
A live webcast of Petco’s presentation, and a replay available about two hours later, will be accessible through the company’s investor relations website at ir.petco.com. The company also issued a press release dated August 21, 2025, which is included as an exhibit to this report.